Clinical Trial Update: WEUSKOP5723: Prostate Cancer Study

View source ↗

Summary

The WEUSKOP5723 clinical trial sponsored by GlaxoSmithKline has completed, studying a compound for prostatic conditions. The listed condition is benign prostati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• WEUSKOP5723

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prostatic Hyperplasia | Status: COMPLETED